Page last updated: 2024-10-30

metformin and Gigantism

metformin has been researched along with Gigantism in 3 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Gigantism: The condition of accelerated and excessive GROWTH in children or adolescents who are exposed to excess HUMAN GROWTH HORMONE before the closure of EPIPHYSES. It is usually caused by somatotroph hyperplasia or a GROWTH HORMONE-SECRETING PITUITARY ADENOMA. These patients are of abnormally tall stature, more than 3 standard deviations above normal mean height for age.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
García-Beltran, C1
Cereijo, R1
Quesada-López, T1
Malpique, R1
López-Bermejo, A1
de Zegher, F1
Ibáñez, L1
Villarroya, F1
Kuo, SF1
Chuang, WY1
Ng, S1
Chen, CH1
Chang, CN1
Chou, CH1
Weng, WC1
Yeh, CH1
Lin, JD1
Ali, O1
Banerjee, S1
Kelly, DF1
Lee, PD1

Trials

1 trial available for metformin and Gigantism

ArticleYear
Reduced circulating levels of chemokine CXCL14 in adolescent girls with polycystic ovary syndrome: normalization after insulin sensitization.
    BMJ open diabetes research & care, 2020, Volume: 8, Issue:1

    Topics: Adipocytes; Adipogenesis; Adipose Tissue, Brown; Adolescent; Arrhythmias, Cardiac; Biomarkers; Chemo

2020

Other Studies

2 other studies available for metformin and Gigantism

ArticleYear
Pituitary gigantism presenting with depressive mood disorder and diabetic ketoacidosis in an Asian adolescent.
    Journal of pediatric endocrinology & metabolism : JPEM, 2013, Volume: 26, Issue:9-10

    Topics: Adenoma; Adolescent; Adolescent Development; Antineoplastic Agents, Hormonal; Combined Modality Ther

2013
Management of type 2 diabetes mellitus associated with pituitary gigantism.
    Pituitary, 2007, Volume: 10, Issue:4

    Topics: Adenoma; Adolescent; Antineoplastic Agents; Cabergoline; Combined Modality Therapy; Diabetes Mellitu

2007